Simulect OverviewBasiliximab (trade name Simulect) is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants. Contents 1 Uses 2 Mechanism of action 3 Chemistry 4 History 5 References and notes Uses Basiliximab is an immunosuppressant agent used to prevent immediate transplant rejection in people who are receiving kidney transplants, in combination with other agents...
Read more Simulect Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Basiliximab
Recent Simulect Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 10mg, 20mg
- Vial: 10mg, 20mg
NDC Database Records for Simulect: (2 results)Sorted by National Drug Code
- 0078-0331 Simulect 20 mg/5ml Intravenous Injection, Powder, for Solution by Novartis Pharmaceuticals Corporation
- 0078-0393 Simulect 10 mg/2.5ml Intravenous Injection, Powder, for Solution by Novartis Pharmaceuticals Corporation